royal-peptides.com
OFFICIAL ROYAL PEPTIDES WEBSITE You are on royal-peptides.com
VERIFY OFFICIAL SITE

Royal Peptides

ROYAL RESEARCH CATALOG

Retatrutide 10-Vial Bulk Kit RT

Research Material Batch Documentation Secure Checkout
Price range: $380 through $1,500

Buy Retatrutide (LY3437943) online in the USA in 10-vial research kits, available in multiple research quantities. Batch identification and applicable analytical documentation are available through the Royal Peptides COA library.

For laboratory research use only. Not for human or veterinary use.

Choose an option
Clear selection
01Research focusedLaboratory research materials
02DocumentedAvailable batch information
03TrackedOrder fulfillment updates
Secure payment VISA link $
RESEARCH NOTICE
For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.
View Documentation →
Research Material • LY3437943

Retatrutide Research Reference

Retatrutide, also identified in scientific literature by the development code LY3437943, is an investigational peptide-based compound. Royal Peptides supplies Retatrutide in multi-vial research-kit formats for laboratory, analytical, and scientific research applications.

This page serves as the primary Royal Peptides reference for Retatrutide research kits, compound identification, available research quantities, batch traceability, and analytical documentation.

Retatrutide LY3437943 10-Vial Research Kits Batch Traceability Analytical Documentation
Compound Identity

Retatrutide / LY3437943

Retatrutide is the official name associated with the investigational compound also referenced as LY3437943 or LY-3437943 in public scientific and regulatory databases.

Compound identifiers below are provided to help researchers distinguish Retatrutide from similarly named materials and locate corresponding scientific records. They describe the published reference compound and should not be interpreted as a substitute for lot-specific analytical characterization of any physical research sample.

Common name Retatrutide
Development identifier LY3437943
CAS Registry Number 2381089-83-2
FDA UNII NOP2Y096GV
Molecular formula* C221H342N46O68
Published molecular mass* ≈ 4,731 g/mol
Material class Peptide research material
Royal Peptides format 10-vial research kits
i

*Scientific-reference values: molecular data shown here refer to the published compound record and do not constitute batch-specific analytical verification. Researchers should use documentation corresponding to the actual production lot when evaluating a supplied material.

Scientific Context

A Compound Under Active Investigation

Public scientific records describe Retatrutide as an investigational peptide designed to interact with GIP, GLP-1, and glucagon receptor systems. The compound has been investigated within an extensive clinical-development program and remains an investigational molecule rather than an approved medicine.

Royal Peptides references this scientific background solely to establish compound identity and research context. Published studies involving an investigational molecule do not establish the composition, identity, purity, performance, or suitability of a separate commercial research sample.

Compound Identification

Public identifiers such as Retatrutide, LY3437943, CAS 2381089-83-2, and UNII NOP2Y096GV help establish a consistent reference to the scientific compound.

Analytical Research

Laboratory evaluation may involve appropriate analytical techniques selected by qualified researchers according to the objectives and controls of the research workflow.

Published Literature

Scientific literature may be consulted for historical, structural, and experimental context concerning the published Retatrutide reference molecule.

Lot-Specific Evidence

Analytical information relating to a particular physical sample should be associated with the applicable production lot rather than inferred from general literature.

Research Kit Format

Retatrutide 10-Vial Research Kits

This product page is dedicated to Royal Peptides 10-vial Retatrutide research kits. Available kit quantities are presented through the product variation selector above, allowing laboratories to select the research quantity appropriate to their procurement requirements.

A kit variation represents ten vials of the selected nominal research quantity. The currently available variation list, pricing, and inventory status shown by WooCommerce should be treated as the current product record.

One Product, Multiple Variations

Research-kit quantities are organized as variations of this primary Retatrutide kit product instead of creating a separate product page for every available quantity.

Kit Identification

Product and batch identification should be retained with the kit packaging and associated laboratory records.

!

Individual vial labeling may differ from retail single-vial products. Refer to the product notice displayed above the long description and retain kit-level product and batch identification with the material.

Research Procurement Guide

Comparing 10-Vial Kits & Bulk Research Orders

Evaluating larger research quantities? Our 2026 procurement guide explains the differences between 10-vial peptide kits, wholesale Retatrutide, wholesale Tirzepatide, and 100+ vial bulk research orders.

The guide covers unit-cost comparison, price-per-milligram evaluation, third-party analytical documentation, lot traceability, U.S. fulfillment, and factors laboratories can consider when comparing bulk peptide suppliers.

Analytical Documentation

Batch Identification & COA Records

Royal Peptides maintains analytical documentation for applicable research-material lots. Because analytical results relate to the material evaluated from a specific production batch, researchers should match documentation to the corresponding lot whenever batch-level information is available.

01 — Identify the Material

Confirm the product name, selected research quantity, batch or lot reference, and other identifying information supplied with the research material.

02 — Match the Batch

Use the applicable lot reference to locate corresponding analytical documentation rather than relying on a report associated with a different production batch.

03 — Review the Report

Review the analytical methods, reported results, laboratory information, and sample identifiers contained in the available documentation.

04 — Preserve Traceability

Retain relevant product, lot, analytical, receipt, and storage records with the laboratory's internal research documentation.

Research Traceability

Why Lot-Level Documentation Matters

A scientific publication describes the molecule investigated by the authors. A database record describes a referenced chemical or biological entity. Neither independently verifies the characteristics of a physical vial supplied in a separate production batch.

For that reason, Royal Peptides distinguishes compound-reference information from batch-specific analytical information. The latter should be used when documenting the actual research material incorporated into a laboratory workflow.

Compound Identity Production Lot Analytical Record Traceability
Alternative Research Format

Need Individual Retatrutide Vials?

This page covers Royal Peptides 10-vial Retatrutide research kits. Researchers requiring smaller individual quantities can review the separate Retatrutide single-vial product.

Keeping the two formats separate provides clearer product identification while allowing each page to present information specific to its respective research-material format.

Retatrutide FAQ

Retatrutide Research Questions

What is Retatrutide?

Retatrutide is the official name associated with the investigational peptide compound also identified as LY3437943. Royal Peptides supplies a research material bearing this compound designation exclusively for laboratory, analytical, and scientific research.

Is LY3437943 the same research identifier associated with Retatrutide?

Yes. LY3437943 and LY-3437943 appear in scientific and regulatory records as development identifiers associated with Retatrutide.

What is the CAS number associated with Retatrutide?

The validated NCATS substance record for Retatrutide lists CAS Registry Number 2381089-83-2. This identifier refers to the published compound record and does not replace lot-specific analytical documentation for a supplied research sample.

What does a Retatrutide kit variation contain?

This product is organized as a 10-vial research-kit product. Selecting a variation above determines the nominal research quantity associated with each vial in that kit. Current variation availability is displayed directly by the product selector.

Are Retatrutide single vials available separately?

Yes. Royal Peptides maintains a separate Retatrutide Single Vial product for researchers requiring individual research quantities rather than the 10-vial kit format.

Is batch-specific analytical documentation available?

Analytical documentation may be available for applicable production lots. Researchers should use the lot or batch information associated with the material received to identify corresponding documentation in the Royal Peptides COA library.

Why should a COA be matched to a specific lot?

Analytical results describe the sample evaluated by the testing laboratory. Matching the report to the applicable production lot helps maintain traceability between the physical research material and its associated analytical record.

Is Retatrutide an approved medicine?

No. Retatrutide remains an investigational molecule and is not an approved medicine. Royal Peptides does not offer this research material for therapeutic, diagnostic, clinical, human, or veterinary use.

Does Royal Peptides provide Retatrutide dosing or administration instructions?

No. Royal Peptides does not provide dosing, prescribing, injection, administration, treatment, or personal-use instructions for this research material.

Research Use Only

Laboratory Research Material

Royal Peptides Retatrutide is supplied exclusively for laboratory, analytical, and scientific research purposes. It is not intended for human or veterinary use, ingestion, injection, administration, pharmaceutical compounding, diagnostic use, therapeutic use, clinical use, or personal experimentation.

0